**Core Concept**
The patient's presentation and history suggest a condition affecting the lungs, specifically the interstitial spaces, due to long-term use of amiodarone, a well-known iodine-rich antiarrhythmic medication. This condition is associated with pulmonary toxicity, which can manifest as interstitial lung disease (ILD).

**Why the Correct Answer is Right**
Amiodarone-induced pulmonary toxicity is characterized by damage to the pneumocytes, particularly type I pneumocytes, which are responsible for gas exchange in the alveoli. The damage to these cells leads to disruption of the alveolar-capillary membrane, resulting in impaired gas exchange and progressive difficulty in breathing.

**Why Each Wrong Option is Incorrect**
**Option A:** Type II pneumocytes are primarily responsible for surfactant production and are not the primary cells damaged in amiodarone-induced pulmonary toxicity.
**Option B:** Alveolar macrophages play a role in the pathogenesis of various lung diseases but are not the primary cells damaged in this condition.
**Option C:** Fibroblasts are involved in the repair process and are not the primary cells damaged in amiodarone-induced pulmonary toxicity.

**Clinical Pearl / High-Yield Fact**
Amiodarone-induced pulmonary toxicity is a well-known side effect of long-term amiodarone use, and patients on this medication should undergo regular pulmonary function tests (PFTs) and chest X-rays to monitor for signs of ILD.

**Correct Answer:** C. Type I pneumocytes are damaged in amiodarone-induced pulmonary toxicity.